Retrovirus News and Research

RSS

Experts discuss PEPFAR funding in congressional hearing

At a recent hearing of the House Subcommittee on Africa and Global Health, "[i]nternational health organisations working to help check the spread of AIDS in Africa said meagre increases in funds from the U.S. government this year would be a step backwards. Some experts also emphasised that prevention must get appropriate attention in any fight against the disease," Inter Press Service reports.

15 Mar 2010

UNAIDS director cautions against funding cuts to Global Fund

During an appeal to government and private donors to pledge money to the Global Fund to Fight AIDS, Tuberculosis and Malaria on Monday, UNAIDS Executive Director Michel Sidibe warned of the repercussions tightening budgets could play in the global fight against HIV/AIDS, the Associated Press reports.

10 Mar 2010

Glencoe Enterprise article highlights medical innovation and research enable people to live longer, healthier

An article in the Glencoe Enterprise recently highlighted the fact that medical innovation and research are enabling many people to live longer, healthier and more productive lives.

5 Mar 2010

Elsevier releases special issue to mark the 25th anniversary of antiretroviral drug development

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, released a special issue of the journal Antiviral Research (www.sciencedirect.com/science/journal/01663542), marking the 25th anniversary of antiretroviral drug development.

4 Mar 2010

Medical innovation and research: A real boon for American patients to live longer, healthier

An article in the Suislaw News recently highlighted the fact that medical innovation and research are enabling many people to live longer, healthier and more productive lives.

26 Feb 2010

LifeSciences British Columbia, UBC to host global summit on HIV/AIDS

LifeSciences British Columbia, the BC Centre of Excellence in HIV/AIDS, and the University of British Columbia will host a global summit on HIV/AIDS on Feb. 26th, 2010, against the backdrop of the 2010 Olympic Games.

24 Feb 2010

PointCare Technologies donates rapid PointCare NOW tests to Haitian clinics

PointCare Technologies, pioneer inventor of a portable diagnostic system that enables effective HIV/AIDS monitoring for millions of people in remote areas of developing countries, has donated 4,000 (a month's supply) of its rapid PointCare NOW tests to Haitian clinics to ensure the resumption of critical care to HIV/AIDS patients.

24 Feb 2010

Medical innovation: A real boon for American patients

An article in the Journal Miner recently highlighted the fact that many people are living longer, healthier and more productive lives thanks to medical innovation and research.

24 Feb 2010

El Tejano Magazine article: Medical innovation and research help many Americans live longer, healthier

An article that recently appeared in El Tejano Magazine highlighted the fact that many Americans are living longer, healthier and more productive lives because of medical innovation and research.

20 Feb 2010

AHF to protest Merck’s Isentress pricing and policies at CROI

AIDS Healthcare Foundation (AHF) will host a protest Wednesday morning, February 17 at 8:00am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, the most expensive first-line AIDS treatment in the US, during the 17th Conference of Retroviruses and Opportunistic Infections (CROI) in San Francisco.

17 Feb 2010

CNRS-Institut researchers identify 'virulence factor' that inhibits host immune response

Oncogenic retroviruses are a particular family of viruses that can cause some types of cancer. Thierry Heidmann and his colleagues in the CNRS-Institut Gustave Roussy-Université Paris Sud 11 "Rétrovirus endogènes et éléments rétroïdes des eucaryotes supérieurs" Laboratory have studied these viruses. They have identified a "virulence factor" that inhibits the host immune response and allows the virus to spread throughout the body.

16 Feb 2010

New discovery lays foundation for development of new anti-HIV drugs

A team of scientists at The Scripps Research Institute has identified two compounds that act on novel binding sites for an enzyme used by the human immunodeficiency virus (HIV), the virus that causes AIDS.

4 Feb 2010

Also in Global Health News: Retrovirus enzyme; audit of USAID program; Africa's agriculture

A study published on Sunday in the journal Nature has shed light on the enzyme integrase, "which is found in retroviruses like HIV and is a target for some of the newest HIV medicines," Reuters reports. Scientists at the Imperial College London and Harvard University grew a crystal of integrase in the lab allowing them to see the enzyme's structure. According to the news service, the scientists "said that having the integrase structure means researchers can begin fully to understand how integrase inhibitor drugs work, how they might be improved, and how to stop HIV developing resistance to them," according to the news service (Kelland, 2/1).

2 Feb 2010

Breakthrough in HIV research leads to better treatment potential

Researchers have made a breakthrough in HIV research that had eluded scientists for over 20 years, potentially leading to better treatments for HIV, in a study published today in the journal Nature.

31 Jan 2010

Particle Sciences to share responsibilities in developing anti-HIV microbicides

Particle Sciences, a leading drug development CRO, will share formulation, analytic and production responsibilities in an effort to develop a vaginally administered microbicide, a product specifically designed to prevent the sexual transmission of HIV.

28 Jan 2010

Report highlights challenges facing Obama in Africa

A new report highlights challenges facing the Obama administration in Africa, including HIV/AIDS, poverty and climate change, VOA News reports.

27 Jan 2010

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Sangamo BioSciences, Inc. announced today that preliminary data from the University of Pennsylvania investigator sponsored Phase 1 safety study of Sangamo's zinc finger nuclease (ZFN) based product, SB-728-T, for HIV/AIDS were presented on Friday, January 15, 2010 at the Keystone Symposium Session "HIV Biology and Pathogenesis."

20 Jan 2010

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that it has begun enrolling patients in INSPIRE 2, a Phase IIa clinical program evaluating the company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107), in the treatment of chronically HIV-1 infected patients classified as Immunological Non Responders (INR) after at least 12 months of highly active anti-retroviral therapy (HAART).

12 Jan 2010

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

NanoViricides, Inc. (the "Company"), reports that the Company has been invited to present on January 12th at the Biotech Showcase™, a conference designed to showcase promising companies and technologies for partnering and investment purposes.

12 Jan 2010

Pharmaceutical companies working on nearly 100 life-changing medicines for HIV/AIDS

Medical News Today recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 100 life-changing medicines for diseases affecting people with HIV/AIDS, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA).

8 Jan 2010

Retrovirus News and Research

Experts discuss PEPFAR funding in congressional hearing

UNAIDS director cautions against funding cuts to Global Fund

Glencoe Enterprise article highlights medical innovation and research enable people to live longer, healthier

Elsevier releases special issue to mark the 25th anniversary of antiretroviral drug development

Medical innovation and research: A real boon for American patients to live longer, healthier

LifeSciences British Columbia, UBC to host global summit on HIV/AIDS

PointCare Technologies donates rapid PointCare NOW tests to Haitian clinics

Medical innovation: A real boon for American patients

El Tejano Magazine article: Medical innovation and research help many Americans live longer, healthier

AHF to protest Merck’s Isentress pricing and policies at CROI

CNRS-Institut researchers identify 'virulence factor' that inhibits host immune response

New discovery lays foundation for development of new anti-HIV drugs

Also in Global Health News: Retrovirus enzyme; audit of USAID program; Africa's agriculture

Breakthrough in HIV research leads to better treatment potential

Particle Sciences to share responsibilities in developing anti-HIV microbicides

Report highlights challenges facing Obama in Africa

Preliminary data from Phase 1 study of Sangamo BioSciences' SB-728-T announced

Cytheris commences enrollment in its recombinant human Interleukin-7 INSPIRE 2 program for HIV

NanoViricides outlines its technology and current drug programs at Biotech Showcase conference

Pharmaceutical companies working on nearly 100 life-changing medicines for HIV/AIDS

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News